Cargando…
375. The Effect of Inhaled Interferon Beta-1a (SNG001) Treatment Compared to Placebo on Lung Antiviral Biomarkers and Viral Clearance in Chronic Obstructive Pulmonary Disease (COPD) Patients With Respiratory Virus Infections
BACKGROUND: Respiratory viral infections (RVIs) are major drivers of chronic obstructive pulmonary disease (COPD) exacerbations. Interferon beta (IFN-β) is key in host defence against viruses but can be suppressed by virus or host factors locally at the site of infection. Inhalation of SNG001 (IFN-β...
Autores principales: | Monk, Phillip D, Brookes, Jody L, Tear, Victoria J, Batten, Toby, Newall, Clare, Mankowski, Marcin, Crooks, Michael G, Singh, Dave, Chaudhuri, Rekha, Lunn, Kerry, Reynolds, Sophie, Dudley, Sarah, Gabbay, Felicity, Holgate, Stephen T, Djukanovic, Ratko, Wilkinson, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678701/ http://dx.doi.org/10.1093/ofid/ofad500.445 |
Ejemplares similares
-
Nebulised interferon-β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III study
por: Monk, Phillip D., et al.
Publicado: (2023) -
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
por: Monk, Phillip D, et al.
Publicado: (2021) -
Introduction to SNG and ENG microwave
por: Higgins, Jonathan
Publicado: (2004) -
The stability and robustness analysis of SNG and PNG supply
por: Zhu, Jianhua, et al.
Publicado: (2020) -
Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial
por: Jagannathan, Prasanna, et al.
Publicado: (2023)